These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 493987)

  • 21. Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects.
    Krahn DD; Gosnell BA; Levine AS; Morley JE
    Brain Res; 1988 Mar; 443(1-2):63-9. PubMed ID: 2834018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anorectic and other behavioral effects of centrally administered calcitonins.
    Cooper CW; Twery MJ; Lewis MH; Mailman RB
    Psychopharmacol Bull; 1984; 20(3):451-5. PubMed ID: 6473647
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of calcitonin on central neurons in the rat.
    Gerber U; Felix D; Felder M; Schaffner W
    Neurosci Lett; 1985 Oct; 60(3):343-8. PubMed ID: 4069442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of picomolar intracerebroventricular administration of calcitonin on intestinal motility in the rat (author's transl)].
    Bueno L
    C R Seances Acad Sci III; 1982 May; 294(17):881-6. PubMed ID: 6809251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium intake by rats: influence of parathyroid hormone, calcitonin, and 1,25-dihydroxyvitamin D.
    Tordoff MG; Hughes RL; Pilchak DM
    Am J Physiol; 1998 Jan; 274(1):R214-31. PubMed ID: 9458921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcitonin: aversive effects in rats?
    Deutsch JA
    Science; 1981 Feb; 211(4483):733-4. PubMed ID: 7455712
    [No Abstract]   [Full Text] [Related]  

  • 27. Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats.
    Mollet A; Gilg S; Riediger T; Lutz TA
    Physiol Behav; 2004 Mar; 81(1):149-55. PubMed ID: 15059694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Procalcitonin N-terminal peptide causes catabolic effects via the hypothalamus and prostaglandin-dependent pathways.
    Tavares E; Miñano FJ
    Neuroendocrinology; 2008; 88(4):316-26. PubMed ID: 18781060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraperitoneal and intracranial cholecystokinin depress operant responding for food.
    Maddison S
    Physiol Behav; 1977 Dec; 19(6):819-24. PubMed ID: 204952
    [No Abstract]   [Full Text] [Related]  

  • 30. Cholecystokinin octapeptide: continuous picomole injections into the cerebral ventricles of sheep suppress feeding.
    Della-Fera MA; Baile CA
    Science; 1979 Oct; 206(4417):471-3. PubMed ID: 504989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
    Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP
    Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of gastric secretion in man by oral administration of calcitonin.
    Ziegler R; Minne H; Hotz J; Goebell H
    Digestion; 1974; 11(1-2):157-60. PubMed ID: 4615958
    [No Abstract]   [Full Text] [Related]  

  • 33. Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment.
    Tang-Christensen M; Vrang N; Larsen PJ
    Diabetes; 1998 Apr; 47(4):530-7. PubMed ID: 9568683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats.
    Larsen PJ; Fledelius C; Knudsen LB; Tang-Christensen M
    Diabetes; 2001 Nov; 50(11):2530-9. PubMed ID: 11679431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcitonin-induced impairment in conditioning is antagonized by chronic antidepressant drug treatment.
    Aboufatima R; Chait A; Dalal A; de Beaurepaire R
    Therapie; 1999; 54(5):573-7. PubMed ID: 10667092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The satiety effect of growth hormone-releasing factor in rats.
    Imaki T; Shibasaki T; Hotta M; Masuda A; Demura H; Shizume K; Ling N
    Brain Res; 1985 Aug; 340(1):186-8. PubMed ID: 3928093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcitonin gene-related peptide mimics calcitonin actions in brain on growth hormone release and feeding.
    Tannenbaum GS; Goltzman D
    Endocrinology; 1985 Jun; 116(6):2685-7. PubMed ID: 2986959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of serum-prolactin after subcutaneous salmon calcitonin.
    Carman JS; Wyatt RJ
    Lancet; 1977 Jun; 1(8024):1267-8. PubMed ID: 68374
    [No Abstract]   [Full Text] [Related]  

  • 39. Fourth ventricular alloxan injection causes feeding but not hyperglycemia in rats.
    Ritter S; Strang M
    Brain Res; 1982 Oct; 249(1):198-201. PubMed ID: 7139297
    [No Abstract]   [Full Text] [Related]  

  • 40. Eating, drinking and urine output after prolonged cerebroventricular vasopressin infusions in rats.
    Jerome ML; Barbella YR; Wurpel J; Keil LC; Severs WB
    Pharmacology; 1983; 26(2):79-84. PubMed ID: 6844391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.